Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aniflazym 5mg gastro-resistant tablets
1003010V0BBAAAA
|
Aniflazym | Serrapeptase | Musculoskeletal and Joint Diseases | No data available |
|
Anturan 100mg tablets
1001040P0BBAAAA
|
Anturan | Sulfinpyrazone | Musculoskeletal and Joint Diseases | No data available |
|
Anturan 200mg tablets
1001040P0BBABAC
|
Anturan | Sulfinpyrazone | Musculoskeletal and Joint Diseases | No data available |
|
Arava 100mg tablets
1001030L0BBACAC
|
Arava | Leflunomide | Musculoskeletal and Joint Diseases | No data available |
|
Arthrofen 200 tablets
1001010J0B1ADAD
|
Arthrofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrofen 400 tablets
1001010J0B1AEAE
|
Arthrofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrofen 600 tablets
1001010J0B1AFAF
|
Arthrofen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin 250 tablets
1001010P0BDACAD
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin 500 tablets
1001010P0BDADAE
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin EC 250 tablets
1001010P0BDAFAH
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Arthrosin EC 500 tablets
1001010P0BDAEAI
|
Arthrosin | Naproxen | Musculoskeletal and Joint Diseases | No data available |
|
Auranofin 3mg tablets
1001030A0AAAAAA
|
Auranofin | Auranofin | Musculoskeletal and Joint Diseases | No data available |
|
Axorid 100mg/20mg modified-release capsules
1001010L0BQAAAM
|
Axorid | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Axorid 200mg/20mg modified-release capsules
1001010L0BQABAN
|
Axorid | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Azapropazone 300mg capsules
1001010B0AAAAAA
|
Azapropazone | Azapropazone | Musculoskeletal and Joint Diseases | No data available |
|
Azapropazone 600mg tablets
1001010B0AAABAB
|
Azapropazone | Azapropazone | Musculoskeletal and Joint Diseases | No data available |
|
Baclofen 10mg/20ml solution for infusion ampoules
1002020C0AAA4A4
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | No data available |
|
Baclofen 10mg/5ml solution for infusion ampoules
1002020C0AAA3A3
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | No data available |
|
Baclofen 2mg/5ml oral liquid
1002020C0AAA8A8
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | No data available |
|
Baclofen 40mg/20ml solution for infusion ampoules
1002020C0AABFBF
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | No data available |
|
Baclofen 50micrograms/1ml solution for injection ampoules
1002020C0AAA2A2
|
Baclofen | Baclofen | Musculoskeletal and Joint Diseases | No data available |
|
Baclospas 10mg tablets
1002020C0BCAAAI
|
Baclospas-10 | Baclofen | Musculoskeletal and Joint Diseases | No data available |
|
Balsamka muscle balm
100302000BBAWA0
|
Proprietary compound preparation BNF 1003020 | Other rubefacient and topical antirheumatic preparations | Musculoskeletal and Joint Diseases | No data available |
|
Belimumab 120mg powder for solution for infusion vials
1001030Z0AAAAAA
|
Belimumab | Belimumab | Musculoskeletal and Joint Diseases | No data available |
|
Belimumab 400mg powder for solution for infusion vials
1001030Z0AAABAB
|
Belimumab | Belimumab | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.